Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Identify the Immunogenicity and Safety of Inavtivated Quadrivalent Influenza Virus Split Vaccine in Children Aged 3-8 Years With Two Doses and One Dose Pre-immunization

NCT05389137 is registered in ClinicalTrials.gov with Wuhan Institute of Biological Products Co., Ltd as lead sponsor.

NCT NCT05389137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Identify the Immunogenicity and Safety of Inavtivated Quadrivalent Influenza Virus Split Vaccine in Children Aged 3-8 Years With Two Doses and One Dose Pre-immunization
Lead sponsor
Wuhan Institute of Biological Products Co., Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
March 2, 2022
Completion date
October 31, 2022
Enrollment
360 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza